Nano-X Imaging Reports Q1 Loss, Issues Going Concern Warning Amid Rapid Cash Depletion
Summary
Nano-X Imaging reported an increased Q1 net loss and issued a 'going concern' warning due to insufficient cash to fund operations for the next year, alongside withdrawing its 2026 revenue target and future guidance.
Key Events
-
Going Concern Warning Issued
Management expects current cash and equivalents are insufficient to support operations for at least one year, raising substantial doubt about the company's ability to continue as a going concern.
-
Significant Cash Depletion
Cash, cash equivalents, and deposits decreased from $60.0 million to $44.2 million in Q1 2026, with negative cash flow from operations of $14.0 million. Estimated cash as of the filing date is approximately $27 million.
-
Withdrawal of Revenue Guidance
The company no longer expects to achieve its previously announced 2026 revenue target and will cease providing annual revenue guidance due to variability in deployment timelines and revenue recognition.
-
Increased Net Loss
Nano-X Imaging reported a net loss of $14.3 million for Q1 2026, an increase from $13.2 million in Q1 2025.
Analysis
Nano-X Imaging has reported a significant increase in net loss for Q1 2026 and, more critically, issued a 'going concern' warning, stating that its current cash reserves are insufficient to fund operations for the next year. The company experienced a substantial cash burn of $14 million from operations in Q1, with total cash and equivalents dropping from $60 million to $44.2 million, and an estimated $27 million remaining as of the filing date. This severe liquidity crunch, coupled with the withdrawal of its 2026 revenue target and future annual guidance, signals significant operational and financial distress. Additionally, the company disclosed a new class action lawsuit, adding to its legal and financial risks.
At the time of this filing, NNOX was trading at $1.52 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $109.3M. The 52-week trading range was $1.50 to $5.69. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.